Form 8-K - Current report:
SEC Accession No. 0001792044-21-000033
Filing Date
2021-11-08
Accepted
2021-11-08 08:27:17
Documents
13
Period of Report
2021-11-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtrs-20211108.htm   iXBRL 8-K 35339
2 EX-99.1 exhibit991-3q21earningsrel.htm EX-99.1 559921
  Complete submission text file 0001792044-21-000033.txt   776275

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20211108.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20211108_lab.xml EX-101.LAB 24275
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20211108_pre.xml EX-101.PRE 13040
6 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20211108_htm.xml XML 11878
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 211386627
SIC: 2834 Pharmaceutical Preparations